It is a business services private limited company based in Chennai, Tamil Nadu, India, established in 2020.
2020 | Chennai, Tamil Nadu, India | ActiveOagwin Pharmaceuticals Private Limited, a active private limited company, was established on 05 November 2020 in Chennai, Tamil Nadu, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74999TN2020PTC139208. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Its leadership includes Venu Gopal Davuluri (Director), Bolla Divya (Director), Swetha Thatisetti (Additional Director). Past directors included Mohammad Ali Shaik, Riyaz Basha Mohammed, Ahamed Ali Shaik. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.3A , Roja Nagar Ext Madhavaram, Chennai, Tamil Nadu, 600060.
U74999TN2020PTC139208
139208
05 November 2020
₹1.00 M
₹0.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Oagwin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venu Gopal Davuluri | Director | 04 Nov 2022 | Current |
| Bolla Divya | Director | 04 Nov 2022 | Current |
| Swetha Thatisetti | Additional Director | 01 Dec 2022 | Current |
| Sadikha Shaik | Additional Director | 01 Dec 2022 | Current |
| Thatisetti Venkata Pavan Kumar | Director | 04 Nov 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Nov 2022 | Past |
| Pramod Abcsdd | Director | 04 Nov 2022 | Past |
| Pramod Abcsdd | Director | 28 Oct 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oagwin Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.93% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Oagwin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Oagwin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Oagwin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oagwin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Oagwin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Oagwin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was recorded as a recent event.
Swetha Thatisetti was appointed as a Additional Director was appointed as a Additional Director on 01 Dec 2022 & has been associated with this company since 3 years 22 days . was recorded as a recent event.
Sadikha Shaik was appointed as a Additional Director was appointed as a Additional Director on 01 Dec 2022 & has been associated with this company since 3 years 22 days . was recorded as a recent event.
Venu Gopal Davuluri was appointed as a Director was appointed as a Director on 04 Nov 2022 & has been associated with this company since 3 years 1 month . was recorded as a recent event.
Bolla Divya was appointed as a Director was appointed as a Director on 04 Nov 2022 & has been associated with this company since 3 years 1 month . was recorded as a recent event.
The CIN of Oagwin Pharmaceuticals Private Limited is U74999TN2020PTC139208.
Oagwin Pharmaceuticals Private Limited is headquartered at No.3A , Roja Nagar Ext Madhavaram, Chennai, Tamil Nadu, 600060.
Oagwin Pharmaceuticals Private Limited was incorporated on 05 November 2020.
The current directors of Oagwin Pharmaceuticals Private Limited are
The primary industry of Oagwin Pharmaceuticals Private Limited is Business Services.
Oagwin Pharmaceuticals Private Limited is unlisted.
The authorized capital of Oagwin Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX